Overview
Community Health Systems Q2 revenue of $3.133 bln beats analyst expectations
Adjusted EBITDA of $380 mln surpasses estimates, despite a slight decline yr/yr
Net income of $282 mln, a significant improvement from last year's net loss
Result Drivers
REVENUE DECLINE - Net operating revenues for Q2 2025 decreased by 0.2% to $3.133 bln, attributed to a 7.4% decrease in admissions and an 8.3% decrease in adjusted admissions compared to the same period in 2024
INCOME INCREASE - Net income rose to $282 mln, or $2.09 per share, from a net loss of $13 mln, or $(0.10) per share, in Q2 2024, driven by gains from early debt extinguishment and sales of businesses, per CEO Tim L. Hingtgen
ADMISSIONS - On a same-store basis, admissions increased by 0.3% while adjusted admissions decreased by 0.7% in Q2 2025 compared to the same period in 2024
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$3.13 bln
$3.02 bln (7 Analysts)
Q2 Adjusted EBITDA
Beat
$380 mln
$376.10 mln (9 Analysts)
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 5 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Community Health Systems Inc is $4.13, about 6.9% above its July 22 closing price of $3.84
Press Release: ID:nBw6V0Gyva
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)